Dow Up 1.63% Nasdaq Up 0.97%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
6.45 0.57(8.12%) Oct 17, 4:00PM EDT
Prev Close:7.02
Open:7.20
Bid:6.40 x 500
Ask:6.50 x 1000
1y Target Est:17.75
Beta:3.09
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.25 - 7.32
52wk Range:5.47 - 27.63
Volume:5,254,032
Avg Vol (3m):4,665,380
Market Cap:341.26M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRDown 8.12%341.26M
APNTN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,122.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback